Evidence map›Paper›PMID 36097810›Full record

ArticleeLife2022

Regional importation and asymmetric within-country spread of SARS-CoV-2 variants of concern in the Netherlands.

Alvin X Han, Eva Kozanli, Jelle Koopsen, Harry Vennema, RIVM COVID-19 molecular epidemiology group, Karim Hajji, Annelies Kroneman, Ivo van Walle, Don Klinkenberg, Jacco Wallinga and 3 more

Abstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Alvin X HanDepartment of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, Amsterdam, Netherlands.ORCID 0000-0001-6281-8498
Eva KozanliDepartment of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, Amsterdam, Netherlands.
Jelle KoopsenDepartment of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, Amsterdam, Netherlands.
Harry VennemaCentre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
RIVM COVID-19 molecular epidemiology groupCentre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
Karim HajjiCentre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
Annelies KronemanCentre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
Ivo van WalleCentre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
Don KlinkenbergCentre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
Jacco WallingaCentre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
Colin A RussellDepartment of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, Amsterdam, Netherlands.
Dirk EgginkDepartment of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, Amsterdam, Netherlands.
Chantal ReuskenCentre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands.

Funding

Forecasting influenza epidemics using a mechanistic epidemic modelR01AI132362 · NIAID · KAISER FOUNDATION RESEARCH INSTITUTE · PI MANGIONE-SMITH, RITA · 2017 to 2020
$1.0M
NIAID NIH HHS R01 AI132362
6 · The paper itself

Abstract

Background: Variants of concern (VOCs) of SARS-CoV-2 have caused resurging waves of infections worldwide. In the Netherlands, the Alpha, Beta, Gamma, and Delta VOCs circulated widely between September 2020 and August 2021. We sought to elucidate how various control measures, including targeted flight restrictions, had impacted the introduction and spread of these VOCs in the Netherlands. Methods: We performed phylogenetic analyses on 39,844 SARS-CoV-2 genomes collected under the Dutch national surveillance program. Results: We found that all four VOCs were introduced before targeted flight restrictions were imposed on countries where the VOCs first emerged. Importantly, foreign introductions, predominantly from other European countries, continued during these restrictions. After their respective introductions into the Netherlands, the Alpha and Delta VOCs largely circulated within more populous regions of the country with international connections before asymmetric bidirectional transmissions occurred with the rest of the country and the VOC became the dominant circulating lineage. Conclusions: Our findings show that flight restrictions had limited effectiveness in deterring VOC introductions due to the strength of regional land travel importation risks. As countries consider scaling down SARS-CoV-2 surveillance efforts in the post-crisis phase of the pandemic, our results highlight that robust surveillance in regions of early spread is important for providing timely information for variant detection and outbreak control. Funding: None.

Indexed as

COVID-19SARS-CoV-2HumansNetherlandsPhylogenyCOVID-19epidemiologyglobal healthinfectious diseasemicrobiologypublic healthSARS-CoV-2viruses

Identifiers

PMID36097810
PMCPMC9470152

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.